SNCA and Parkinson disease: The α-synuclein transgenic animals A30P display similar phenotypic and physiological abnormalities of PD including locomotor dysfunction, formation of insoluble fibrillar aggregates, and slow degeneration of dopaminergic neurons as found in humans (Feany and Bender, 2000).